These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Attenuated Herpes Simplex Virus 1 (HSV-1) Expressing a Mutant Form of ICP6 Stimulates a Strong Immune Response That Protects Mice against HSV-1-Induced Corneal Disease. Davido DJ; Tu EM; Wang H; Korom M; Gazquez Casals A; Reddy PJ; Mostafa HH; Combs B; Haenchen SD; Morrison LA J Virol; 2018 Sep; 92(17):. PubMed ID: 29950407 [TBL] [Abstract][Full Text] [Related]
6. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge. Osorio Y; Ghiasi H J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224 [TBL] [Abstract][Full Text] [Related]
7. Immunization with replication-defective mutants of herpes simplex virus type 1: sites of immune intervention in pathogenesis of challenge virus infection. Morrison LA; Knipe DM J Virol; 1994 Feb; 68(2):689-96. PubMed ID: 8289372 [TBL] [Abstract][Full Text] [Related]
8. The HSV-1 live attenuated VC2 vaccine provides protection against HSV-2 genital infection in the guinea pig model of genital herpes. Bernstein DI; Pullum DA; Cardin RD; Bravo FJ; Dixon DA; Kousoulas KG Vaccine; 2019 Jan; 37(1):61-68. PubMed ID: 30471955 [TBL] [Abstract][Full Text] [Related]
9. Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesis. Naidu SK; Nabi R; Cheemarla NR; Stanfield BA; Rider PJ; Jambunathan N; Chouljenko VN; Carter R; Del Piero F; Langohr I; Kousoulas KG PLoS One; 2020; 15(2):e0228252. PubMed ID: 32027675 [TBL] [Abstract][Full Text] [Related]
10. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease. van Lint AL; Torres-Lopez E; Knipe DM Virology; 2007 Nov; 368(2):227-31. PubMed ID: 17915278 [TBL] [Abstract][Full Text] [Related]
11. A Herpes Simplex Virus 2 (HSV-2) gD Mutant Impaired for Neural Tropism Is Superior to an HSV-2 gD Subunit Vaccine To Protect Animals from Challenge with HSV-2. Wang K; Goodman KN; Li DY; Raffeld M; Chavez M; Cohen JI J Virol; 2016 Jan; 90(1):562-74. PubMed ID: 26559846 [TBL] [Abstract][Full Text] [Related]
12. A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains. Stanfield BA; Stahl J; Chouljenko VN; Subramanian R; Charles AS; Saied AA; Walker JD; Kousoulas KG PLoS One; 2014; 9(10):e109890. PubMed ID: 25350288 [TBL] [Abstract][Full Text] [Related]
13. Distinguishing Features of High- and Low-Dose Vaccine against Ocular HSV-1 Infection Correlates with Recognition of Specific HSV-1-Encoded Proteins. Carr DJJ; Gmyrek GB; Filiberti A; Berube AN; Browne WP; Gudgel BM; Sjoelund VH Immunohorizons; 2020 Oct; 4(10):608-626. PubMed ID: 33037098 [TBL] [Abstract][Full Text] [Related]
14. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection. Da Costa XJ; Morrison LA; Knipe DM Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897 [TBL] [Abstract][Full Text] [Related]
18. Intramuscular Vaccination With the HSV-1(VC2) Live-Attenuated Vaccine Strain Confers Protection Against Viral Ocular Immunopathogenesis Associated With γδT Cell Intracorneal Infiltration. Nabi R; Lewin AC; Collantes TM; Chouljenko VN; Kousoulas KG Front Immunol; 2021; 12():789454. PubMed ID: 34868077 [TBL] [Abstract][Full Text] [Related]
19. Reducing Viral Inhibition of Host Cellular Apoptosis Strengthens the Immunogenicity and Protective Efficacy of an Attenuated HSV-1 Strain. Xu X; He Y; Fan S; Feng M; Jiang G; Wang L; Zhang Y; Liao Y; Li Q Virol Sin; 2019 Dec; 34(6):673-687. PubMed ID: 31506828 [TBL] [Abstract][Full Text] [Related]
20. Maternal immunization with a herpes simplex virus type 2 replication-defective virus reduces visceral dissemination but not lethal encephalitis in newborn mice after oral challenge. Evans IA; Jones CA J Infect Dis; 2002 Jun; 185(11):1550-60. PubMed ID: 12023760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]